Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gut microbiota-brain axis describes a complex, bidirectional information network connecting the gut microbiota and the brain through neural (including vagus nerve), endocrine, immune, and metabolic pathways. This axis influences brain development, cognition, emotional regulation, immune function, and barrier integrity (both gut and blood-brain barriers); disruptions in the axis have been linked to neurodegenerative diseases, psychiatric disorders, and functional gut disorders. As a concept, the gut microbiota-brain axis is being targeted therapeutically via strategies that modify the microbial community (e.g., probiotics, prebiotics, FMT) or its metabolites, rather than through targeting a single molecule or receptor. The axis is neither a discrete molecular entity nor a canonical drug target, but rather a physiological and microbiological network implicated in health and disease.
Modulation of gut microbial composition; Regulation of neuroactive metabolite production (e.g., SCFAs, neurotransmitters); Alteration of immune system signaling; Impact on neuroendocrine signaling (HPA axis)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota-brain axis.